MabCure Inc. is in the StockGuru Spotlight for January 21, 2011

MabCure Inc. is in the StockGuru Spotlight for January 21, 2011

DALLAS, TEXAS : StockGuru announces that MabCure Inc. (OTCBB: MBCI) is in the StockGuru Spotlight.    MabCure is a U.S. biotechnology company whose mission is to change the perception of cancer as being a largely incurable disease. MabCure owns proprietary technology for the creation of unique and highly specific monoclonal antibodies (MAbs), which the company plans to develop as diagnostic tools, imaging agents and therapeutic drugs to treat lethal cancers. The company’s initial focus is on the development of novel diagnostic tests for the early detection of ovarian, prostate, and colorectal cancers, each with multi-billion dollar global market potential. MabCure is also currently exploring the potential of its anti-melanoma antibodies for the development of imaging and therapeutic agents.

On Thursday, the company put out news announcing the signing of a $10,000,000 Equity Funding Facility with Centurion Private Equity, LLC (“Centurion”), an institutional investor managed by Roswell Capital Partners, LLC. MabCure intends to use the funding facility to fund clinical trials and ongoing research and development, and to support general corporate purposes. Centurion has committed to purchase for cash consideration, subject to certain conditions and limitations described in the agreement, up to an aggregate of $10,000,000 of MabCure’s common stock. Under the Equity Funding Facility, MabCure may, at its discretion, periodically sell to Centurion shares of MabCure’s common stock at a price based upon the market price (as defined in the agreement) of MabCure’s common stock. 

Shares for MabCure Inc. (OTCBB: MBCI) were steady during the late afternoon of trading on Thursday and closed with no change at closing.


To view our StockGuru Spotlight on MabCure Inc. (OTCBB: MBCI), please visit: http://www.stockguru.com/category/latest-spotlights/

To get free alerts on this and other similar stocks, please sign up to our newsletter here:
http://www.stockguru.com/?page_id=250

What is the StockGuru Spotlight?

Many companies we cover in The StockGuru Spotlight have positive increases in both volume and share price. While this is not true in all cases, we strive to cover companies in The StockGuru Spotlight that are worth of our attention.

StockGuru most often features in The StockGuru Spotlight companies that have recent news and appear to be getting the attention on investors. We specifically look for stories that are so compelling to small cap investors that one might expect additional investor interest.  StockGuru does not typically feature companies in the StockGuru Spotlight that are compensating us for this coverage.  There are times when we cover a stock in The StockGuru Spotlight that we were long ago compensated on. In those cases we will include a proper disclaimer.  We never hold shares, short shares or have any other interest in a company we feature in The StockGuru Spotlight.

Do you know a company that should be covered in The StockGuru Spotlight?

If you think a company should be featured in the StockGuru Spotlight, please let us know. If you are a key person for a publicly traded company, we can consider your company for either a StockGuru Spotlight or a StockGuru Profile.  Please contact our Publisher John Pentony at the john@stockguru.com.  You may also telephone John Pentony at (469) 252-3030. 

Stockguru.com (“SG”) provides its members with the latest news, press releases, and trade alerts for all the companies highlighted on the site StockGuru.com. SG utilizes information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by SG to be accurate, and should not be considered to be all-inclusive. The owner, publisher, editor and their associates are not responsible for errors and omissions. We never buy in the market in advance of any Profile or Spotlight coverage.  We never sell into the market as we are issuing information on our web site or on any news wire. SG encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SG makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed onhttp://www.Stockguru.com or mentioned herein. 

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected”, “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies= annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SG undertakes no obligation to update such statements. StockGuru is occassionally compensated for coverage.  When this is the case, we indicate clearly with a disclosure of all compensation received in the past and present.  Additionally we also disclose any anticipated compensation in the future.  Compensation is typically in cash.  Sometimes a third party shareholder pays us in free trading shares. Sometimes a company pays us in restricted shares. StockGuru is not a registered investment adviser or a broker/dealer. StockGuru makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. 


John Pentony, Publisher, Stockguru.com Tel: +1 469 252 3031 e-mail: john@stockguru.com

Left Menu Icon
Right Menu Icon